Examples of using Prostatic hyperplasia in English and their translations into Russian
{-}
-
Official
-
Colloquial
(1) Benign prostatic hyperplasia.
This enlarged prostate is clinically known as Benign Prostatic Hyperplasia or BPH.
BPH, or benign prostatic hyperplasia, is the second main problem that can occur in the prostate.
The condition is also called benign prostatic hyperplasia(BPH).
Keywords: benign prostatic hyperplasia; transurethral endoscopic surgery; URO-HYAL; hyaluronic acid drugs.
Medical doctors call this condition of enlarged prostate BPH or"benign prostatic hyperplasia.
Used for benign prostatic hyperplasia;
The treatment of patients with lower urinary tract disorders associated with benign prostatic hyperplasia.
This includes coverage for benign prostatic hyperplasia or enlarged prostate in men.
Differential Approach To The Treatment Of Lower Urinary Tract Symptoms In Benign Prostatic Hyperplasia.
Excess estradiol in men can cause benign prostatic hyperplasia, gynecomastia, and symptoms of hypogonadism.
Older men are at risk for prostate cancer as well, but it is much less common than benign prostatic hyperplasia.
It is used as a treatment in benign prostatic hyperplasia(BPH) in low doses, and prostate cancer in higher doses.
This enlarged prostate is clinically known as Benign Prostatic Hyperplasia or BPH.
Keywords: benign prostatic hyperplasia; bipolar transurethral resection; medium-sized prostatic hyperplasia. .
Use Of The Selective Alfa -1-adrenoblocker Tamsulosin(sonizin) In Patients With Benign Prostatic Hyperplasia And Arterial Hypertension.
The enlarged prostate called benign prostatic hyperplasia or prostate depends on the conversion of testosterone to dihydro-testosterone.
Effect of Preoperative Urodynamic Detrusor Underactivity on Transurethral Surgery for Benign Prostatic Hyperplasia.
Dutasteride is occasionally used for treating benign prostatic hyperplasia(BPH); colloquially known as an"enlarged prostate".
Prostatilen is used as monotherapy for chronic nonbacterial prostatitis andas a component of complex therapy for bacterial prostatitis and benign prostatic hyperplasia.
Dysuric disorders after endoscopic surgery for benign prostatic hyperplasia(BPH) are observed in the majority of patients on day 2-3 after urethral catheter withdrawal.
Changes in Adenosine Triphosphate andNitric Oxide in the Urothelium of Patients with Benign Prostatic Hyperplasia and Detrusor Underactivity.
Some patients diagnosed with benign prostatic hyperplasia may be recommended to undergo a surgical procedure called an open prostatectomy, or surgery to remove the prostate.
Use Of The Selective Alfa -1-adrenoblocker Tamsulosin(sonizin)In Patients With Benign Prostatic Hyperplasia And Arterial Hypertension.
Benign prostatic hyperplasia(obsolete- prostate adenoma) is a benign tumor, an increase in the number of cells of the periurethral glands of the prostate, the most common disease in older men.
And saw palmetto extracts pidzheuma included in Formula bioactive complex capable of reducing male prostatic hyperplasia, especially at the initial stage of the disease.
Effects of Withdrawing α1-Blocker from CombinationTherapy with α1-Blocker and 5α-Reductase Inhibitor in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia.
The article generalizes the experience of conducting simultaneous minimally invasive interventions for benign prostatic hyperplasia and urolithiasis of the lower urinary tract is summarized.
It was proven that the glands,which cause the prostatic hyperplasia, produce special antagonist substances to male sex hormones, as the result of which the decrease in their concentration in blood causes the disturbance of balance of male and female sex hormones in the organism of a man that leads to active expansion of cells of these glands.
These could consist of enhanced oily skin, acne, hair development raises in the face and body, and dangers involving male pattern baldness(MPB)in addition to benign prostatic hyperplasia(BPH).
